Skip to main content
SillaJen, Inc. logo

SillaJen, Inc. — Investor Relations & Filings

Ticker · 215600 ISIN · KR7215600008 KO Professional, scientific and technical activities
Open in API
Filings indexed 402 across all filing types
Latest filing 2025-05-29 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 215600

About SillaJen, Inc.

https://www.sillajen.com/

SillaJen, Inc. is a biotechnology company focused on the research and development of oncolytic immunotherapeutics for cancer treatment. The company engineers genetically modified viruses designed to selectively target and destroy cancer cells while stimulating a systemic anti-tumor immune response. Its lead product candidate is Pexa-Vec (JX-594), an oncolytic vaccinia virus developed for the treatment of various solid tumors. SillaJen's core activity involves advancing its pipeline of novel cancer-fighting viral therapies through clinical development.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a '정정신고' (Amendment Report). It details changes to previously reported stock option grants, including adjustments to the number of shares and the list of recipients. This type of disclosure regarding stock-based compensation and capital structure changes falls under the category of regulatory filings that do not fit into specific categories like 10-K or M&A, and is best classified as a general regulatory filing.
2025-05-29 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a corporate merger (회사합병 결정) between SillaJen and its subsidiary Woosung Pharmaceutical. It details the merger schedule, rationale, financial impact, and legal compliance. This type of filing is a regulatory disclosure required by the Korea Exchange (KRX) for significant corporate events. Since it is a detailed report on M&A activity rather than a simple announcement of a report, it falls under the M&A Activity category.
2025-05-27 Korean
[기재정정]분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for SillaJen, Inc. covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial statements, including the statement of cash flows, and business descriptions. It is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-22 Korean
[기재정정]사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a 'Correction Report' (정정신고) for an Annual Report (사업보고서) filed by SillaJen, Inc. It explicitly lists corrections to financial statements (Income Statements) and management information, which are components of an Annual Report. Since it is a formal regulatory filing containing substantive financial data and corrections to a previously filed annual report, it is classified as an Annual Report (10-K). FY 2024
2025-05-15 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for SillaJen, Inc., covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial information, business operations, management discussions, and corporate governance details, which are characteristic of a formal quarterly financial report. It is not an announcement of a report (RPA) or a simple certification, but the full report itself. Q1 2025
2025-05-15 Korean
주요사항보고서(회사합병결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a merger decision (회사합병 결정) between SillaJen (the parent company) and its 100% subsidiary, Woosung Pharmaceutical. It details the merger method, purpose, financial impact, and timeline. This type of filing is a standard regulatory disclosure for M&A activity in the Korean market, which falls under the 'M&A Activity' category.
2025-04-24 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.